The molecular profiling of prostate cancer with liquid bioipsies, such as circulating tumor cells (CTCs) and circulating tumor DNA (ct-DNA) analysis, concerning the presence of AR-V7 in tumor cells provides informative evaluation of tumor prognosis. The gene discussed is AR; the disease is neoplasm.